Ann: SPONTAN achieves positive clinical study results, page-184

Well, have to keep in mind the drug itself is not new at all, so they know the drug works with men who suffer ED. Viagra was the first mover. The trial was more about the delivery method. The trials were very successful in that response time was significantly quicker than the traditional pill method. It's a potential game changer to this market for the practical use of this drug.

I can see this product being used by more than just ED sufferers. Anxiety issues seem to be more common these days, particularly with younger generations. Guys who have this issue, may like to have this product in case they 'get lucky' but then have a performance issue.......easily fixed in 10 minutes with a discreet nasal spray!

The other interesting point is that often patients stop using the pill method after less than a year. If Sponton becomes a longer term solution, then that recurring revenue over years makes the ED market even bigger. I have read that the ED market is anywhere from 4-7 billion (AUD) a year...depending what you read..... if Spontan becomes a market disrupter and even just gains 25% market share.......do the maths of what that means per share! But, they most likely get taken out by a bigger pharma company before that? Either way....potentially a lot of upside here.